Drug Licensing

Big Pharma's China Deal Spree Grows With Latest Tie-Up Worth Up to $7.8 Billion

Western biopharmaceutical companies are increasingly turning to China to source innovation as the industry's looming patent cliff draws closer, according to CNBC.